These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 805220)

  • 21. [Prenatal determination of the fetal blood group].
    Meroni P; Della Torre L
    Ann Ostet Ginecol Med Perinat; 1969 Jul; 91(7):497-507. PubMed ID: 4997558
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of the antigenicity of factors A and B in the newborn].
    Ducos J; Ohayon E; Marty Y
    Rev Fr Transfus; 1969; 12(1):Suppl:37-43. PubMed ID: 5393863
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility].
    Trifan N; Lupaşcu G; Trifan E
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):1049-54. PubMed ID: 4135203
    [No Abstract]   [Full Text] [Related]  

  • 24. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease.
    Rath ME; Smits-Wintjens VE; Lindenburg IT; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
    Vox Sang; 2011 Apr; 100(3):312-6. PubMed ID: 20849463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An example of anti-Coa found in pregnancy.
    Smith DS; Stratton F; Howell P; Riches R
    Vox Sang; 1970 Jan; 18(1):62-6. PubMed ID: 4984719
    [No Abstract]   [Full Text] [Related]  

  • 26. Exchange transfusion in newborn infants with perinatal hemolytic disease. Efficacy of the procedure.
    Ceccon ME; Diniz EM; Ramos JL; Vaz FA
    Rev Paul Med; 1993; 111(2):348-53. PubMed ID: 8284577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Icterus gravis in ABO incompatibility and bilirubin coupling disorders].
    Stur O
    Wien Med Wochenschr; 1970 May; 120(22):400-1. PubMed ID: 5534805
    [No Abstract]   [Full Text] [Related]  

  • 28. [A clinical case of pregnancy isoimmunization caused by the Kell system].
    Orsini G; Serratì A; Schonauer S; Cramarossa D
    Minerva Ginecol; 1977 Oct; 29(10):727-30. PubMed ID: 593610
    [No Abstract]   [Full Text] [Related]  

  • 29. [Results of the blood serum examination for the presence of anti-ABO system antibodies in mothers of newborn infants with fetal erythroblastosis requiring exchange transfusion].
    Cwik J
    Pediatr Pol; 1988 Sep; 63(9):563-8. PubMed ID: 3253666
    [No Abstract]   [Full Text] [Related]  

  • 30. Anti-ce (anti-f) in a CDe-cD-mother, as a cause of haemolytic disease of the newborn.
    Spielmann W; Seidl S; von Pawel J
    Vox Sang; 1974; 27(5):473-7. PubMed ID: 4213590
    [No Abstract]   [Full Text] [Related]  

  • 31. [Incidence of materno-fetal isoimmunization against the Rh factor (D)].
    Marmorino C
    Minerva Med; 1972 Dec; 63(86):4699-707. PubMed ID: 4629911
    [No Abstract]   [Full Text] [Related]  

  • 32. [JKa isoimmunization following the I.U.F.T. performed in erythroblastosis fetalis due to Rh incompatibility].
    Franchini E; Valbonesi M; Santi F; Porro E
    Ann Ostet Ginecol Med Perinat; 1975; 96(6):404-5. PubMed ID: 818933
    [No Abstract]   [Full Text] [Related]  

  • 33. Prediction of the occurrence of erythroblastosis fetalis by antenatal Rh testing and its treatment by complete exchange transfusion.
    WIENER AS
    Pittsbg Med Bull; 1946 Nov; 35(39):778-86. PubMed ID: 20281084
    [No Abstract]   [Full Text] [Related]  

  • 34. PROBLEMS IN THE MANAGEMENT OF ERYTHROBLASTOSIS FETALIS. III. FURTHER OBSERVATIONS ON CASES WITH UNUSUAL SEROLOGIC AND CLINICAL FINDINGS.
    WIENER AS; BRANCATO GJ; WEXLER IB
    Exp Med Surg; 1964; 22():1-12. PubMed ID: 14164354
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the wait-and-see attitude in the management of newborns with Rh erythroblastosis].
    Dortmann A; Küster F; Stapper H
    Arch Kinderheilkd; 1967 May; 175(3):236-42. PubMed ID: 4967237
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemolytic disease of the newborn due to ABO incompatibility (author's transl)].
    Fischer K; Poschmann A; Grundmann A
    Z Geburtshilfe Perinatol; 1977 Aug; 181(4):227-40. PubMed ID: 410177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evolution of indications of exchange transfusion in the newborn. Criteria for renewed transfusion (apropos of 1200 cases)].
    Streiff F; Raffoux C; Genetet B; Dejean M
    Rev Fr Transfus; 1973 Sep; 16(3):299-309. PubMed ID: 4210205
    [No Abstract]   [Full Text] [Related]  

  • 38. Non-rhesus (D) blood group isoimmunization in obstetrics.
    Beal RW
    Clin Obstet Gynaecol; 1979 Dec; 6(3):493-508. PubMed ID: 116796
    [No Abstract]   [Full Text] [Related]  

  • 39. ABO hemolytic disease.
    Cook LN
    Clin Obstet Gynecol; 1982 Jun; 25(2):333-9. PubMed ID: 7105509
    [No Abstract]   [Full Text] [Related]  

  • 40. Rhesus anti-E, anti-c antibodies as a cause of hemolytic disease of the newborn.
    Nair PM; Sabarinathan K; Jayaprakash PA; Vijayalekshmi
    Indian Pediatr; 1983 Sep; 20(9):681-4. PubMed ID: 6427106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.